as 3201 has been researched along with Cataract in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bril, V; Kuromiya, A; Matsumoto, T; Ono, Y; Toyosawa, K; Ueda, Y | 1 |
1 other study(ies) available for as 3201 and Cataract
| Article | Year |
|---|---|
Long-term treatment with ranirestat (AS-3201), a potent aldose reductase inhibitor, suppresses diabetic neuropathy and cataract formation in rats.
Topics: Aldehyde Reductase; Animals; Cataract; Diabetic Neuropathies; Enzyme Inhibitors; Pyrazines; Rats; Spiro Compounds | 2008 |